{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:33:37Z","timestamp":1790696017596,"version":"4.1.0"},"reference-count":102,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2018.00123","type":"journal-article","created":{"date-parts":[[2018,4,20]],"date-time":"2018-04-20T04:15:36Z","timestamp":1524197736000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":58,"title":["Epstein\u2013Barr Virus in Gliomas: Cause, Association, or Artifact?"],"prefix":"10.3389","volume":"8","author":[{"given":"Saghir","family":"Akhtar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Semir","family":"Vranic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhan Sachal","family":"Cyprian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ala-Eddin","family":"Al Moustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,4,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2017.12.039","article-title":"Brain tumors","author":"McFaline-Figueroa","year":"2018","journal-title":"Am J Med"},{"key":"B2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21442","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"B3","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1146\/annurev-pathol-121808-102109","article-title":"The pathobiology of glioma tumors","volume":"5","author":"Gladson","year":"2010","journal-title":"Annu Rev Pathol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1056\/NEJMra0708126","article-title":"Malignant gliomas in adults","volume":"359","author":"Wen","year":"2008","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1001\/jama.2015.16669","article-title":"Maintenance therapy with tumor-treating fields plus temozolomide vs temozolomide alone for glioblastoma: a randomized clinical trial","volume":"314","author":"Stupp","year":"2015","journal-title":"JAMA"},{"key":"B6","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1093\/neuonc\/noq191","article-title":"Temozolomide in the treatment of high-grade gliomas in children: a report from the Children\u2019s Oncology Group","volume":"13","author":"Cohen","year":"2011","journal-title":"Neuro Oncol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1093\/neuonc\/nou087","article-title":"The epidemiology of glioma in adults: a \u201cstate of the science\u201d review","volume":"16","author":"Ostrom","year":"2014","journal-title":"Neuro Oncol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.22034\/APJCP.2017.18.1.3","article-title":"Glioblastoma multiforme: a review of its epidemiology and pathogenesis through clinical presentation and treatment","volume":"18","author":"Hanif","year":"2017","journal-title":"Asian Pac J Cancer Prev"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1038\/mt.2013.80","article-title":"Cell-based immunotherapy against gliomas: from bench to bedside","volume":"21","author":"Bovenberg","year":"2013","journal-title":"Mol Ther"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1200\/JCO.2017.73.9516","article-title":"Insights from molecular profiling of adult glioma","volume":"35","author":"Diamandis","year":"2017","journal-title":"J Clin Oncol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s11912-017-0585-6","article-title":"The effect of molecular diagnostics on the treatment of glioma","volume":"19","author":"Bush","year":"2017","journal-title":"Curr Oncol Rep"},{"key":"B12","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1002\/path.4282","article-title":"Using the molecular classification of glioblastoma to inform personalized treatment","volume":"232","author":"Olar","year":"2014","journal-title":"J Pathol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1093\/annonc\/mdx106","article-title":"Glioblastoma targeted therapy: updated approaches from recent biological insights","volume":"28","author":"Touat","year":"2017","journal-title":"Ann Oncol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.12688\/f1000research.11493.1","article-title":"Glioblastoma update: molecular biology, diagnosis, treatment, response assessment, and translational clinical trials","volume":"6","author":"Lieberman","year":"2017","journal-title":"F1000Res"},{"key":"B15","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/neuonc\/nov136","article-title":"Isocitrate dehydrogenase mutations in gliomas","volume":"18","author":"Waitkus","year":"2016","journal-title":"Neuro Oncol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1093\/jnci\/djq187","article-title":"Isocitrate dehydrogenase 1 and 2 mutations in cancer: alterations at a crossroads of cellular metabolism","volume":"102","author":"Reitman","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"B17","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s00401-015-1432-1","article-title":"Glioblastoma: pathology, molecular mechanisms and markers","volume":"129","author":"Aldape","year":"2015","journal-title":"Acta Neuropathol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"114371","DOI":"10.18632\/oncotarget.22825","article-title":"Genomic alterations of ERBB receptors in cancer: clinical implications","volume":"8","author":"Mishra","year":"2017","journal-title":"Oncotarget"},{"key":"B19","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.cell.2013.09.034","article-title":"The somatic genomic landscape of glioblastoma","volume":"155","author":"Brennan","year":"2013","journal-title":"Cell"},{"key":"B20","doi-asserted-by":"publisher","first-page":"512","DOI":"10.3892\/ol.2017.6221","article-title":"Epidermal growth factor receptor in glioblastoma","volume":"14","author":"Xu","year":"2017","journal-title":"Oncol Lett"},{"key":"B21","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3389\/fonc.2015.00005","article-title":"Current therapeutic advances targeting EGFR and EGFRvIII in glioblastoma","volume":"5","author":"Padfield","year":"2015","journal-title":"Front Oncol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s13277-015-4240-2","article-title":"MGMT testing allows for personalised therapy in the temozolomide era","volume":"37","author":"Dullea","year":"2016","journal-title":"Tumour Biol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/nrneurol.2014.100","article-title":"MGMT testing \u2013 the challenges for biomarker-based glioma treatment","volume":"10","author":"Wick","year":"2014","journal-title":"Nat Rev Neurol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1056\/NEJMoa043331","article-title":"MGMT gene silencing and benefit from temozolomide in glioblastoma","volume":"352","author":"Hegi","year":"2005","journal-title":"N Engl J Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"S104","DOI":"10.1016\/j.semcancer.2015.03.007","article-title":"Therapeutic targeting of replicative immortality","volume":"35","author":"Yaswen","year":"2015","journal-title":"Semin Cancer Biol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"317","DOI":"10.2217\/imt-2017-0122","article-title":"Current state and future prospects of immunotherapy for glioma","volume":"10","author":"Kamran","year":"2018","journal-title":"Immunotherapy"},{"key":"B27","doi-asserted-by":"publisher","first-page":"5150678","DOI":"10.1155\/2017\/5150678","article-title":"The role of microglia and macrophages in CNS homeostasis, autoimmunity, and cancer","volume":"2017","author":"Yin","year":"2017","journal-title":"J Immunol Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/aps.2017.173","article-title":"MicroRNAs as biomarkers for human glioblastoma: progress and potential","author":"Huang","year":"2018","journal-title":"Acta Pharmacol Sin"},{"key":"B29","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.tim.2016.03.008","article-title":"Viral carcinogenesis beyond malignant transformation: EBV in the progression of human cancers","volume":"24","author":"Elgui de Oliveira","year":"2016","journal-title":"Trends Microbiol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s11060-011-0658-6","article-title":"The roles of viruses in brain tumor initiation and oncomodulation","volume":"105","author":"Kofman","year":"2011","journal-title":"J Neurooncol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1128\/CMR.00124-13","article-title":"Viruses and human cancers: a long road of discovery of molecular paradigms","volume":"27","author":"White","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"B32","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1750-9378-8-7","article-title":"Role of infectious agents in the carcinogenesis of brain and head and neck cancers","volume":"8","author":"Alibek","year":"2013","journal-title":"Infect Agent Cancer"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1593\/neo.81178","article-title":"The story of human cytomegalovirus and cancer: increasing evidence and open questions","volume":"11","author":"Michaelis","year":"2009","journal-title":"Neoplasia"},{"key":"B34","doi-asserted-by":"publisher","first-page":"221","DOI":"10.21873\/invivo.11049","article-title":"Prevalence of neurotropic viruses in malignant glioma and their onco-modulatory potential","volume":"31","author":"Strojnik","year":"2017","journal-title":"In Vivo"},{"key":"B35","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s40478-016-0338-z","article-title":"A comprehensive next generation sequencing-based virome assessment in brain tissue suggests no major virus-tumor association","volume":"4","author":"Strong","year":"2016","journal-title":"Acta Neuropathol Commun"},{"key":"B36","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1093\/jnci\/djp031","article-title":"Activation of telomerase by human cytomegalovirus","volume":"101","author":"Straat","year":"2009","journal-title":"J Natl Cancer Inst"},{"key":"B37","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.jcv.2007.11.009","article-title":"HCMV microinfections in inflammatory diseases and cancer","volume":"41","author":"Soderberg-Naucler","year":"2008","journal-title":"J Clin Virol"},{"key":"B38","first-page":"3347","article-title":"Human cytomegalovirus infection and expression in human malignant glioma","volume":"62","author":"Cobbs","year":"2002","journal-title":"Cancer Res"},{"key":"B39","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1215\/15228517-2007-035","article-title":"Sensitive detection of human cytomegalovirus in tumors and peri-pheral blood of patients diagnosed with glioblastoma","volume":"10","author":"Mitchell","year":"2008","journal-title":"Neuro Oncol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00401-008-0359-1","article-title":"Detection of human cytomegalovirus in different histological types of gliomas","volume":"116","author":"Scheurer","year":"2008","journal-title":"Acta Neuropathol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13027-016-0081-x","article-title":"Human herpesvirus multiplex ddPCR detection in brain tissue from low- and high-grade astrocytoma cases and controls","volume":"11","author":"Lin","year":"2016","journal-title":"Infect Agent Cancer"},{"key":"B42","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/S0140-6736(64)91524-7","article-title":"Virus particles in cultured lymphoblasts from Burkitt\u2019s lymphoma","volume":"1","author":"Epstein","year":"1964","journal-title":"Lancet"},{"key":"B43","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/j.1365-2613.2001.iep190.x","article-title":"Epstein-Barr virus infection and human malignancies","volume":"82","author":"Niedobitek","year":"2001","journal-title":"Int J Exp Pathol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3390\/jcm6120111","article-title":"Viral oncology: molecular biology and pathogenesis","volume":"6","author":"Mui","year":"2017","journal-title":"J Clin Med"},{"key":"B45","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1128\/CMR.00044-10","article-title":"Progress and problems in understanding and managing primary Epstein-Barr virus infections","volume":"24","author":"Odumade","year":"2011","journal-title":"Clin Microbiol Rev"},{"key":"B46","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.virusres.2016.11.002","article-title":"The interaction between human papillomavirus and other viruses","volume":"231","author":"Guidry","year":"2017","journal-title":"Virus Res"},{"key":"B47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1040-8428(02)00078-1","article-title":"Pathogenic roles for Epstein-Barr virus (EBV) gene products in EBV-associated proliferative disorders","volume":"45","author":"Middeldorp","year":"2003","journal-title":"Crit Rev Oncol Hematol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1038\/nrc1452","article-title":"Epstein-Barr virus: 40 years on","volume":"4","author":"Young","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"B49","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1002\/rmv.1780","article-title":"Switching of EBV cycles between latent and lytic states","volume":"24","author":"Murata","year":"2014","journal-title":"Rev Med Virol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1158\/1078-0432.CCR-0670-3","article-title":"Epstein-Barr virus and cancer","volume":"10","author":"Thompson","year":"2004","journal-title":"Clin Cancer Res"},{"key":"B51","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.semcancer.2008.10.002","article-title":"Immune escape by Epstein-Barr virus associated malignancies","volume":"18","author":"Munz","year":"2008","journal-title":"Semin Cancer Biol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"9150","DOI":"10.1073\/pnas.90.19.9150","article-title":"Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation","volume":"90","author":"Kaye","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B53","doi-asserted-by":"publisher","first-page":"811","DOI":"10.2217\/fon.09.53","article-title":"Role of the Epstein-Barr virus-encoded latent membrane protein-1, LMP1, in the pathogenesis of nasopharyngeal carcinoma","volume":"5","author":"Morris","year":"2009","journal-title":"Future Oncol"},{"key":"B54","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.semcancer.2012.01.004","article-title":"The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC)","volume":"22","author":"Dawson","year":"2012","journal-title":"Semin Cancer Biol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.ygyno.2017.10.005","article-title":"Association between Epstein-Barr virus (EBV) and cervical carcinoma: a meta-analysis","volume":"148","author":"de Lima","year":"2018","journal-title":"Gynecol Oncol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1002\/cam4.538","article-title":"Early-life exposures to infectious agents and later cancer development","volume":"4","author":"Vedham","year":"2015","journal-title":"Cancer Med"},{"key":"B57","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1002\/path.4459","article-title":"The Epstein-Barr virus and the pathogenesis of lymphoma","volume":"235","author":"Vockerodt","year":"2015","journal-title":"J Pathol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1159\/000085748","article-title":"Investigation of Epstein-Barr virus DNA in formalin-fixed and paraffin-embedded breast cancer tissues","volume":"14","author":"Kalkan","year":"2005","journal-title":"Med Princ Pract"},{"key":"B59","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.clinbiochem.2007.12.017","article-title":"Detection of Epstein-Barr virus in breast carcinoma in Egyptian women","volume":"41","author":"Fawzy","year":"2008","journal-title":"Clin Biochem"},{"key":"B60","doi-asserted-by":"publisher","first-page":"e13603","DOI":"10.1371\/journal.pone.0013603","article-title":"Characterization of Epstein Barr virus latency pattern in Argentine breast carcinoma","volume":"5","author":"Lorenzetti","year":"2010","journal-title":"PLoS One"},{"key":"B61","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/j.prp.2011.09.007","article-title":"Investigation of Epstein-Barr virus in breast carcinomas in Tunisia","volume":"207","author":"Hachana","year":"2011","journal-title":"Pathol Res Pract"},{"key":"B62","doi-asserted-by":"publisher","first-page":"e48788","DOI":"10.1371\/journal.pone.0048788","article-title":"Epstein-Barr virus, human papillomavirus and mouse mammary tumour virus as multiple viruses in breast cancer","volume":"7","author":"Glenn","year":"2012","journal-title":"PLoS One"},{"key":"B63","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jnci.2012.06.001","article-title":"Epstein-Barr virus and breast cancer: epidemiological and molecular study on Egyptian and Iraqi women","volume":"24","author":"Zekri","year":"2012","journal-title":"J Egypt Natl Canc Inst"},{"key":"B64","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1080\/21645515.2015.1009342","article-title":"Incidence of Epstein-Barr virus in Syrian women with breast cancer: a tissue microarray study","volume":"11","author":"Aboulkassim","year":"2015","journal-title":"Hum Vaccin Immunother"},{"key":"B65","doi-asserted-by":"publisher","first-page":"509296","DOI":"10.1155\/2012\/509296","article-title":"Advances in virus-directed therapeutics against Epstein-Barr virus-associated malignancies","volume":"2012","author":"Ghosh","year":"2012","journal-title":"Adv Virol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s10555-017-9693-x","article-title":"Progression of understanding for the role of Epstein-Barr virus and management of nasopharyngeal carcinoma","volume":"36","author":"Nakanishi","year":"2017","journal-title":"Cancer Metastasis Rev"},{"key":"B67","doi-asserted-by":"publisher","first-page":"e0186860","DOI":"10.1371\/journal.pone.0186860","article-title":"Epstein-Barr virus infection and oral squamous cell carcinoma risk: a meta-analysis","volume":"12","author":"She","year":"2017","journal-title":"PLoS One"},{"key":"B68","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1002\/pros.22562","article-title":"Human papillomavirus and Epstein Barr virus in prostate cancer: koilocytes indicate potential oncogenic influences of human papillomavirus in prostate cancer","volume":"73","author":"Whitaker","year":"2013","journal-title":"Prostate"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1936","DOI":"10.1080\/21645515.2016.1139255","article-title":"Co-prevalence of Epstein-Barr virus and high-risk human papillomaviruses in Syrian women with breast cancer","volume":"12","author":"Al Moustafa","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.22034\/APJCP.2017.18.5.1201","article-title":"Malignant salivary gland tumors and Epstein-Barr virus (EBV) infection: a systematic review and meta-analysis","volume":"18","author":"Mozaffari","year":"2017","journal-title":"Asian Pac J Cancer Prev"},{"key":"B71","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1080\/13550280802345715","article-title":"Epstein-Barr virus encephalitis presenting with a tumor-like lesion in an immunosuppressed transplant recipient","volume":"14","author":"Khalil","year":"2008","journal-title":"J Neurovirol"},{"key":"B72","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2169\/internalmedicine.42.33","article-title":"Epstein-Barr virus infections of the central nervous system","volume":"42","author":"Fujimoto","year":"2003","journal-title":"Intern Med"},{"key":"B73","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.4049\/jimmunol.156.6.2247","article-title":"Identification and characterization of complement C3 receptors on human astrocytes","volume":"156","author":"Gasque","year":"1996","journal-title":"J Immunol"},{"key":"B74","doi-asserted-by":"crossref","first-page":"7722","DOI":"10.1128\/JVI.73.9.7722-7733.1999","article-title":"Epstein-Barr virus infection of human astrocyte cell lines","volume":"73","author":"Menet","year":"1999","journal-title":"J Virol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1111\/neup.12276","article-title":"Primary central nervous system lymphomas and related diseases: pathological characteristics and discussion of the differential diagnosis","volume":"36","author":"Sugita","year":"2016","journal-title":"Neuropathology"},{"key":"B76","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1093\/aje\/154.2.161","article-title":"Prevalence of antibodies to four herpesviruses among adults with glioma and controls","volume":"154","author":"Wrensch","year":"2001","journal-title":"Am J Epidemiol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1080\/13550280600654573","article-title":"Lack of association of herpesviruses with brain tumors","volume":"12","author":"Poltermann","year":"2006","journal-title":"J Neurovirol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.prp.2016.12.006","article-title":"An overview of the infection of CMV, HSV 1\/2 and EBV in Mexican patients with glioblastoma multiforme","volume":"213","author":"Zavala-Vega","year":"2017","journal-title":"Pathol Res Pract"},{"key":"B79","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1590\/1516-3180.2013.1912814","article-title":"Frequency of Epstein-Barr virus DNA sequences in human gliomas","volume":"133","author":"Fonseca","year":"2015","journal-title":"Sao Paulo Med J"},{"key":"B80","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.brainres.2008.05.009","article-title":"Detection and quantitative analysis of human herpesvirus in pilocytic astrocytoma","volume":"1221","author":"Neves","year":"2008","journal-title":"Brain Res"},{"key":"B81","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.yexmp.2014.03.010","article-title":"Detection of viral pathogens in high grade gliomas from unmapped next-generation sequencing data","volume":"96","author":"Cimino","year":"2014","journal-title":"Exp Mol Pathol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1002\/ijc.28670","article-title":"Comprehensive metagenomic analysis of glioblastoma reveals absence of known virus despite antiviral-like type I interferon gene response","volume":"135","author":"Cosset","year":"2014","journal-title":"Int J Cancer"},{"key":"B83","doi-asserted-by":"publisher","first-page":"8916","DOI":"10.1128\/JVI.00340-13","article-title":"Landscape of DNA virus associations across human malignant cancers: analysis of 3,775 cases using RNA-Seq","volume":"87","author":"Khoury","year":"2013","journal-title":"J Virol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1750-9378-10-3","article-title":"Prevalence of human cytomegalovirus, polyomaviruses, and oncogenic viruses in glioblastoma among Japanese subjects","volume":"10","author":"Hashida","year":"2015","journal-title":"Infect Agent Cancer"},{"key":"B85","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.mehy.2012.02.003","article-title":"Cytomegalovirus infection in early childhood may be protective against glioblastoma multiforme, while later infection is a risk factor","volume":"78","author":"Lehrer","year":"2012","journal-title":"Med Hypotheses"},{"key":"B86","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nrg.2016.49","article-title":"Coming of age: ten years of next-generation sequencing technologies","volume":"17","author":"Goodwin","year":"2016","journal-title":"Nat Rev Genet"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.5858\/arpa.2016-0501-RA","article-title":"Review of clinical next-generation sequencing","volume":"141","author":"Yohe","year":"2017","journal-title":"Arch Pathol Lab Med"},{"key":"B88","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.3389\/fmicb.2017.01829","article-title":"A review on the applications of next generation sequencing technologies as applied to food-related microbiome studies","volume":"8","author":"Cao","year":"2017","journal-title":"Front Microbiol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"12550","DOI":"10.1073\/pnas.1405839111","article-title":"MRI-localized biopsies reveal subtype-specific differences in molecular and cellular composition at the margins of glioblastoma","volume":"111","author":"Gill","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B90","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1093\/neuonc\/not140","article-title":"Evidence of association of human papillomavirus with prognosis worsening in glioblastoma multiforme","volume":"16","author":"Vidone","year":"2014","journal-title":"Neuro Oncol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s11481-010-9204-0","article-title":"Chronic viral infection and primary central nervous system malignancy","volume":"5","author":"Saddawi-Konefka","year":"2010","journal-title":"J Neuroimmune Pharmacol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1093\/jnci\/92.9.690","article-title":"Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis","volume":"92","author":"zur Hausen","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"B93","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/aje\/kwu176","article-title":"Epstein-Barr virus antibodies and the risk of associated malignancies: review of the literature","volume":"180","author":"Coghill","year":"2014","journal-title":"Am J Epidemiol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"14257","DOI":"10.1038\/ncomms14257","article-title":"Epstein-Barr virus particles induce centrosome amplification and chromosomal instability","volume":"8","author":"Shumilov","year":"2017","journal-title":"Nat Commun"},{"key":"B95","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1056\/NEJMc1302145","article-title":"Survival in patients with glioblastoma receiving valganciclovir","volume":"369","author":"Soderberg-Naucler","year":"2013","journal-title":"N Engl J Med"},{"key":"B96","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/978-3-642-38965-8_14","article-title":"Anti-viral treatment and cancer control","volume":"193","author":"Shih","year":"2014","journal-title":"Recent Results Cancer Res"},{"key":"B97","doi-asserted-by":"publisher","first-page":"507257","DOI":"10.1155\/2012\/507257","article-title":"HIV-associated Hodgkin\u2019s lymphoma: prognosis and therapy in the era of cART","volume":"2012","author":"Jacobson","year":"2012","journal-title":"Adv Hematol"},{"key":"B98","doi-asserted-by":"publisher","first-page":"485943","DOI":"10.1155\/2012\/485943","article-title":"AIDS-related non-Hodgkin\u2019s lymphoma in the era of highly active antiretroviral therapy","volume":"2012","author":"Vishnu","year":"2012","journal-title":"Adv Hematol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3109\/02688697.2013.829554","article-title":"Stupp-treated glioblastoma accompanied by EBV-positive primary CNS lymphoma","volume":"28","author":"Zakaria","year":"2014","journal-title":"Br J Neurosurg"},{"key":"B100","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1038\/cti.2014.27","article-title":"Epstein-Barr virus vaccines","volume":"4","author":"Cohen","year":"2015","journal-title":"Clin Transl Immunology"},{"key":"B101","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1158\/0008-5472.CAN-12-2448","article-title":"Phase I trial of recombinant modified vaccinia ankara encoding Epstein-Barr viral tumor antigens in nasopharyngeal carcinoma patients","volume":"73","author":"Hui","year":"2013","journal-title":"Cancer Res"},{"key":"B102","doi-asserted-by":"publisher","first-page":"13105","DOI":"10.1128\/JVI.05598-11","article-title":"A virus-like particle-based Epstein-Barr virus vaccine","volume":"85","author":"Ruiss","year":"2011","journal-title":"J Virol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fonc.2018.00123\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T06:17:07Z","timestamp":1693635427000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fonc.2018.00123\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,20]]},"references-count":102,"alternative-id":["10.3389\/fonc.2018.00123"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2018.00123","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,20]]},"article-number":"123"}}